Herbalife Nutrition Ltd vs Lockheed Martin Corporation — how do they compare? Herbalife Nutrition Ltd trades at $11.76 (market cap $1.23B), while Lockheed Martin Corporation trades at $605.94 (market cap $137.96B). The key difference: Lockheed Martin Corporation is far larger — about 112.2× Herbalife Nutrition Ltd's market cap, and Lockheed Martin Corporation pays a 2.31% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals.
| HLF | LMT | |
|---|---|---|
Market Cap | $1.23B | $137.96B |
Sector | Consumer Staples | Industrials |
52-Week High | $19.96 | $676.70 |
52-Week Low | $7.75 | $431.56 |
Enterprise Value | $3.06B | $154.71B |
Dividend Yield | — | 2.31% |
Signals from Pluang's Aura AI — not financial advice
HLF trades at $11.71, up 1.65% on the day, with a bearish technical signal from moving averages. The company shows mixed earnings, missing Q2 2026 EPS estimates but achieving four consecutive quarters of sales growth. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels present financial risks. Recent news includes a planned CFO transition and inclusion in TIME's America's Best Companies 2026 list.
The outlook for HLF balances low valuation against operational and financial challenges. Investment opportunity lies in potential margin improvement and debt reduction, but risks include earnings volatility, high leverage, and competitive pressures in the nutrition space. Analyst sentiment is cautiously optimistic with a majority buy rating.
Lockheed Martin (LMT) trades at $601.99, down 0.19% on the day, with a bullish technical signal and strong analyst consensus. The stock shows robust fundamentals with a record $230.4 billion backlog (Seeking Alpha, 2026-08-04), revenue growth to $75.05 billion in 2025, and a net income margin of 8.16%. Recent news highlights major defense contracts, including a $53.9 billion Patriot missile order (The Motley Fool, 2026-08-11), supporting long-term growth.
The outlook for LMT is positive, driven by expanding defense budgets and execution on its backlog, though risks include earnings misses and debt levels. Analysts project a consensus price target of $608, with 57% recommending buy. The stock's valuation metrics, such as a P/E of 22.04, appear reasonable given growth prospects, but investors should monitor contract execution and macroeconomic pressures.
Trailing returns across standard periods
Latest headlines on both assets
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →